Biolife Solutions Inc [BLFS] stock is trading at $25.72, up 8.43%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The BLFS shares have gain 5.93% over the last week, with a monthly amount glided 0.59%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Biolife Solutions Inc [NASDAQ: BLFS] stock has seen the most recent analyst activity on April 04, 2024, when Jefferies initiated its Buy rating and assigned the stock a price target of $22. Previously, Craig Hallum started tracking the stock with Buy rating on July 11, 2023, and set its price target to $29. On April 25, 2022, upgrade upgraded it’s rating to Outperform but maintained its price target of $28 on the stock. B. Riley Securities started tracking the stock assigning a Buy rating and suggested a price target of $61 on October 19, 2021. The Benchmark Company downgraded its rating to Hold for this stock on May 14, 2021. In a note dated March 23, 2021, The Benchmark Company upgraded an Buy rating on this stock but restated the target price of $54.
Biolife Solutions Inc [BLFS] stock has fluctuated between $8.92 and $26.73 over the past year. Currently, Wall Street analysts expect the stock to reach $26 within the next 12 months. Biolife Solutions Inc [NASDAQ: BLFS] shares were valued at $25.72 at the most recent close of the market. An investor can expect a potential return of 1.09% based on the average BLFS price forecast.
Analyzing the BLFS fundamentals
Biolife Solutions Inc [NASDAQ:BLFS] reported sales of 126.11M for the trailing twelve months, which represents a drop of -28.30%. Gross Profit Margin for this corporation currently stands at 0.36% with Operating Profit Margin at -0.44%, Pretax Profit Margin comes in at -0.47%, and Net Profit Margin reading is -0.51%. To continue investigating profitability, this company’s Return on Assets is posted at -0.17, Equity is -0.19 and Total Capital is -0.16. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 24.66 points at the first support level, and at 23.60 for the second support level. However, for the 1st resistance point, the stock is sitting at 26.42, and for the 2nd resistance point, it is at 27.12.
Ratios To Look Out For
For context, Biolife Solutions Inc’s Current Ratio is 2.86. In addition, the Quick Ratio stands at 1.81 and the Cash Ratio stands at 0.72. Considering the valuation of this stock, the price to sales ratio is 9.41, the price to book ratio is 3.69.
Transactions by insiders
Recent insider trading involved Foster Karen A., Chief Quality and Operations, that happened on Sep 16 ’24 when 267.0 shares were sold. Chief Quality and Operations, Foster Karen A. completed a deal on Jul 18 ’24 to sell 240.0 shares. Meanwhile, Chief Quality and Operations Foster Karen A. sold 96.0 shares on Aug 21 ’24.
